For investors in gene therapy biotech bluebird bio, a wait-and-see approach toward a proposed acquisition has paid off. | For ...

The medtech association AdvaMed went to Capitol Hill today to make the case that the medical device industry should be exempt ...

Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is ...

(Reuters) -Bluebird bio and Carlyle Group and SK Capital Partners said on Wednesday that the private equity firms have ...